Bio-Rad Laboratories, Inc. logo
Bio-Rad Laboratories, Inc. (BIO)
Compare

Bio-Rad Laboratories, Inc. (BIO) EV/EBIT Ratio: 36.51x

Is Bio-Rad Laboratories, Inc.’s EV/EBIT ratio high or low?

Bio-Rad Laboratories, Inc.'s EV/EBIT ratio of 36.51x is in line with its 5-year average of 33.28x, around the middle of its 5-year range (22.61x–47.78x).

The EV/EBIT ratio for Bio-Rad Laboratories, Inc. (BIO) is 36.51x as of Wednesday, June 10, 2026. It is below its 12-month average by 3.99% (38.03x).

BIO EV/EBIT Ratio Chart

BIO EV/EBIT Ratio
36.51x+24.14% 1Y
Zoom

BIO Average EV/EBIT Ratio Chart

BIO Current vs Average EV/EBIT Ratio Chart

BIO EV/EBIT Ratio Metrics

EV/EBIT RATIO

36.51x

EV/EBIT RATIO AVG TTM

38.03x

EV/EBIT RATIO AVG 3Y

32.82x

EV/EBIT RATIO AVG 5Y

33.28x

EV/EBIT RATIO AVG 10Y

55.29x

EV/EBIT RATIO AVG 15Y

42.14x

EV/EBIT RATIO AVG 20Y

34.96x

CURRENT VS TTM AVG

-3.99%

CURRENT VS 3Y AVG

+11.23%

CURRENT VS 5Y AVG

+9.69%

CURRENT VS 10Y AVG

-33.97%

CURRENT VS 15Y AVG

-13.36%

CURRENT VS 20Y AVG

+4.42%

BIO Competitors' EV/EBIT Ratio

NAMEMARKET CAPEV/EBIT RATIOTTM3Y5Y
Bio-Rad Laboratories, Inc. (BIO)$7.89B36.51x38.03x32.82x33.28x
Charles River Laboratories International, Inc. (CRL)$9.06B25.46x62.90x38.55x35.16x
Hims & Hers Health, Inc. (HIMS)$6.42B239.52x98.85x147.38x147.38x
Baxter International Inc. (BAX)$10.49BN/A442.63x243.35x134.31x
Align Technology, Inc. (ALGN)$12.56B19.62x19.31x26.46x31.52x
Hologic, Inc. (HOLX)$16.97B24.28x22.66x24.05x18.32x
Moderna, Inc. (MRNA)$18.40BN/A23.08x30.94x30.94x
BioNTech SE (BNTX)$21.81BN/A4.91x5.85x5.85x
Mettler-Toledo International Inc. (MTD)$22.85B21.94x26.09x26.29x29.26x
Waters Corporation (WAT)$23.83B54.60x27.55x26.51x26.24x

Bio-Rad Laboratories, Inc. EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Bio-Rad Laboratories, Inc. EV/EBIT Ratio FAQ

What is the EV/EBIT ratio for Bio-Rad Laboratories, Inc. (BIO)?
The EV/EBIT ratio for BIO stock is 36.51x.
Is Bio-Rad Laboratories, Inc.'s EV/EBIT ratio high or low?
Bio-Rad Laboratories, Inc.'s EV/EBIT ratio of 36.51x is in line with its 5-year average of 33.28x, around the middle of its 5-year range (22.61x–47.78x).
What is the TTM average EV/EBIT ratio for Bio-Rad Laboratories, Inc. (BIO)?
The TTM average EV/EBIT ratio for BIO stock is 38.03x.
What is the 3Y average EV/EBIT ratio for Bio-Rad Laboratories, Inc. (BIO)?
The 3Y average EV/EBIT ratio for BIO stock is 32.82x.
What is the 5Y average EV/EBIT ratio for Bio-Rad Laboratories, Inc. (BIO)?
The 5Y average EV/EBIT ratio for BIO stock is 33.28x.
What is the 10Y average EV/EBIT ratio for Bio-Rad Laboratories, Inc. (BIO)?
The 10Y average EV/EBIT ratio for BIO stock is 55.29x.
What is the 15Y average EV/EBIT ratio for Bio-Rad Laboratories, Inc. (BIO)?
The 15Y average EV/EBIT ratio for BIO stock is 42.14x.
What is the 20Y average EV/EBIT ratio for Bio-Rad Laboratories, Inc. (BIO)?
The 20Y average EV/EBIT ratio for BIO stock is 34.96x.

Bio-Rad Laboratories, Inc. EV/EBIT Ratio History

DATEEV/EBIT RATIO
2026-06-1036.51x
2026-06-0937.09x
2026-06-0836.43x
2026-06-0536.77x
2026-06-0438.25x
2026-06-0337.95x
2026-06-0238.09x
2026-06-0138.02x
2026-05-2938.81x
2026-05-2839.46x
2026-05-2738.00x
2026-05-2637.06x
2026-05-2236.02x
2026-05-2135.91x
2026-05-2036.04x
2026-05-1935.27x
2026-05-1835.36x
2026-05-1531.50x
2026-05-1431.36x
2026-05-1331.05x
2026-05-1230.84x
2026-05-1131.08x
2026-05-0832.26x
2026-05-0732.60x
2026-05-0632.79x
2026-05-0532.58x
2026-05-0432.66x
2026-05-0132.51x
2026-04-3035.17x
2026-04-2936.80x
2026-04-2837.30x
2026-04-2738.23x
2026-04-2438.30x
2026-04-2337.54x
2026-04-2239.82x
2026-04-2140.40x
2026-04-2040.13x
2026-04-1739.62x
2026-04-1638.68x
2026-04-1539.26x
2026-04-1438.82x
2026-04-1338.34x
2026-04-1037.29x
2026-04-0937.08x
2026-04-0837.51x
2026-04-0737.14x
2026-04-0637.24x
2026-04-0237.37x
2026-04-0137.18x
2026-03-3137.23x
2026-03-3036.24x
2026-03-2735.65x
2026-03-2636.97x
2026-03-2536.62x
2026-03-2436.45x
2026-03-2335.61x
2026-03-2035.55x
2026-03-1935.61x
2026-03-1835.96x
2026-03-1736.13x
2026-03-1635.16x
2026-03-1335.35x
2026-03-1235.23x
2026-03-1136.18x
2026-03-1035.94x
2026-03-0936.37x
2026-03-0636.18x
2026-03-0537.26x
2026-03-0437.93x
2026-03-0337.40x
2026-03-0237.33x
2026-02-2737.19x
2026-02-2636.81x
2026-02-2536.15x
2026-02-2436.04x
2026-02-2335.99x
2026-02-2036.35x
2026-02-1936.42x
2026-02-1836.27x
2026-02-1735.60x
2026-02-1334.61x
2026-02-1238.84x
2026-02-1139.48x
2026-02-1040.23x
2026-02-0939.63x
2026-02-0640.41x
2026-02-0540.18x
2026-02-0440.94x
2026-02-0340.11x
2026-02-0239.93x
2026-01-3039.48x
2026-01-2939.63x
2026-01-2840.21x
2026-01-2739.96x
2026-01-2640.15x
2026-01-2339.83x
2026-01-2240.86x
2026-01-2141.61x
2026-01-2041.76x
2026-01-1641.85x
2026-01-1542.87x
2026-01-1442.41x
2026-01-1342.88x
2026-01-1242.98x
2026-01-0943.08x
2026-01-0842.51x
2026-01-0743.11x
2026-01-0643.28x
2026-01-0542.90x
2026-01-0240.87x
2025-12-3140.59x
2025-12-3040.77x
2025-12-2940.68x
2025-12-2640.70x
2025-12-2440.44x
2025-12-2340.36x
2025-12-2240.81x
2025-12-1940.42x
2025-12-1840.22x
2025-12-1740.39x
2025-12-1640.48x
2025-12-1541.18x
2025-12-1241.21x
2025-12-1141.90x
2025-12-1042.03x
2025-12-0941.20x
2025-12-0841.25x
2025-12-0542.35x
2025-12-0442.63x
2025-12-0342.66x
2025-12-0242.45x
2025-12-0142.80x
2025-11-2843.20x
2025-11-2643.46x
2025-11-2544.08x
2025-11-2442.92x
2025-11-2142.23x
2025-11-2040.67x
2025-11-1940.81x
2025-11-1841.16x
2025-11-1740.72x
2025-11-1441.81x
2025-11-1342.25x
2025-11-1243.49x
2025-11-1141.83x
2025-11-1041.12x
2025-11-0740.90x
2025-11-0641.02x
2025-11-0541.43x
2025-11-0441.54x
2025-11-0341.60x
2025-10-3142.57x
2025-10-3040.79x
2025-10-2942.56x
2025-10-2844.88x
2025-10-2745.57x
2025-10-2446.01x
2025-10-2345.88x
2025-10-2245.31x
2025-10-2144.98x
2025-10-2043.84x
2025-10-1742.39x
2025-10-1642.68x
2025-10-1541.88x
2025-10-1441.79x
2025-10-1341.62x
2025-10-1040.89x
2025-10-0941.25x
2025-10-0841.52x
2025-10-0740.75x
2025-10-0642.29x
2025-10-0341.84x
2025-10-0240.47x
2025-10-0140.92x
2025-09-3038.78x
2025-09-2937.53x
2025-09-2637.68x
2025-09-2537.57x
2025-09-2438.32x
2025-09-2338.99x
2025-09-2239.14x
2025-09-1939.23x
2025-09-1839.53x
2025-09-1738.77x
2025-09-1639.01x
2025-09-1538.76x
2025-09-1238.78x
2025-09-1139.45x
2025-09-1038.36x
2025-09-0939.46x
2025-09-0840.00x
2025-09-0540.61x
2025-09-0439.88x
2025-09-0339.72x
2025-09-0240.04x
2025-08-2940.91x
2025-08-2840.40x
2025-08-2740.30x
2025-08-2640.76x
2025-08-2540.85x
2025-08-2241.64x
2025-08-2139.35x
2025-08-2039.73x
2025-08-1939.75x
2025-08-1839.30x
2025-08-1539.42x
2025-08-1439.61x
2025-08-1339.61x
2025-08-1238.10x
2025-08-1136.85x
2025-08-0836.81x
2025-08-0736.94x
2025-08-0636.83x
2025-08-0537.78x
2025-08-0438.35x
2025-08-0139.30x
2025-07-3134.10x
2025-07-3031.61x
2025-07-2931.89x
2025-07-2831.97x
2025-07-2533.20x
2025-07-2432.96x
2025-07-2332.40x
2025-07-2231.09x
2025-07-2130.95x
2025-07-1831.20x
2025-07-1731.56x
2025-07-1631.29x
2025-07-1531.30x
2025-07-1431.69x
2025-07-1132.39x
2025-07-1032.71x
2025-07-0931.95x
2025-07-0831.68x
2025-07-0731.27x
2025-07-0331.78x
2025-07-0231.67x
2025-07-0131.37x
2025-06-3030.62x
2025-06-2730.92x
2025-06-2630.87x
2025-06-2530.58x
2025-06-2430.24x
2025-06-2329.97x
2025-06-2030.11x
2025-06-1829.57x
2025-06-1729.40x
2025-06-1629.54x
2025-06-1329.00x
2025-06-1229.62x
2025-06-1129.37x
2025-06-1029.41x
2025-06-0928.85x
2025-06-0628.15x
2025-06-0528.14x
2025-06-0428.45x
2025-06-0328.28x
2025-06-0227.83x
2025-05-3029.00x
2025-05-2929.08x

Showing the most recent 260 of 4,799 data points. The chart above shows the full history.

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.

Hercules, CA
7,700 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Norman D. Schwartz